Ein von ISO 9001, 14001, 45001 zertifiziertes Unternehmen sales@bldpharm.com
Währung :
Sprache : Deutsch |
Standort :
Standort
  • Americas
    • Europe
      • Asia Pacific
        • Africa & Middle East
          |
          Startseite/ Inhibitors/Agonists/ Metabolic Enzyme/ FXR/ Ursodeoxycholic acid sodium
          Danger

          Sodium (R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate(Ursodeoxycholic acid sodium)
          Synonyms:Ursodeoxycholate sodium;Ursodiol sodium;Ursodeoxycholic Acid (sodium salt)

          Sodium (R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate

          CAS NO.: 2898-95-5  
            Größe Preis Verkaufsrabatt Rabatt Lager-US Lager-IND Lager-EU Lager-Global Menge
            How to Order

            The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

            How to Order

            QUALITÄTSKONTROLLE Batch NO.:

            PRODUKT INFORMATION

            Produkt Name : Sodium (R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
            CAS Nr. : 2898-95-5 Molekulargewicht : 414.55
            MDL Nr. : MFCD00065453 Feinheit/Spezifikation :
            Molekularformel : C24H39NaO4 Lagerung : Inert atmosphere, 2-8°C
            Siedepunkt : -
            GHS Pictogram :
            Signal Word : Danger Precautionary Statements : P501-P261-P270-P271-P264-P280-P361+P364-P301+P310+P330-P302+P352+P312-P304+P340+P311-P403+P233-P405
            UN# : 2811 Class : 6.1
            Hazard Statements : H301+H311+H331 Packing Group :

            ZUSAMMENHÄNGENDE PRODUKTE

            HISTORISCHE AUFZEICHNUNGEN